Rheumatoid arthritis treated with implanted cells that release drug
The Pharma Data
SEPTEMBER 1, 2021
Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. The engineered cells reduced inflammation and prevented a type of damage to bone, known as bone erosion, in a mouse model of rheumatoid arthritis. million adults in the United States.
52 
Let's personalize your content